BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24012840)

  • 21. Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo model.
    Helmy SA; El-Mesery M; El-Karef A; Eissa LA; El Gayar AM
    Life Sci; 2019 Sep; 233():116673. PubMed ID: 31336121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial effect of metronomic chemotherapy on tumor suppression and survival in a rat model of hepatocellular carcinoma with liver cirrhosis.
    Park ST; Jang JW; Kim GD; Park JA; Hur W; Woo HY; Kim JD; Kwon JH; Yoo CR; Bae SH; Choi JY; Yoon SK
    Cancer Chemother Pharmacol; 2010 May; 65(6):1029-37. PubMed ID: 19701751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-myc downstream regulated gene1/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G0/G1 phase.
    Akiba J; Murakami Y; Noda M; Watari K; Ogasawara S; Yoshida T; Kawahara A; Sanada S; Yasumoto M; Yamaguchi R; Kage M; Kuwano M; Ono M; Yano H
    Cancer Lett; 2011 Nov; 310(1):25-34. PubMed ID: 21775055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Artesunate obliterates experimental hepatocellular carcinoma in rats through suppression of IL-6-JAK-STAT signalling.
    Ilamathi M; Prabu PC; Ayyappa KA; Sivaramakrishnan V
    Biomed Pharmacother; 2016 Aug; 82():72-9. PubMed ID: 27470341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thymoquinone attenuates diethylnitrosamine induction of hepatic carcinogenesis through antioxidant signaling.
    Sayed-Ahmed MM; Aleisa AM; Al-Rejaie SS; Al-Yahya AA; Al-Shabanah OA; Hafez MM; Nagi MN
    Oxid Med Cell Longev; 2010; 3(4):254-61. PubMed ID: 20972371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of epithelial cell adhesion molecule (EpCAM) in rat hepatic tumors induced by diethylnitrosamine.
    Kang JS
    Asian Pac J Cancer Prev; 2012; 13(8):3627-30. PubMed ID: 23098445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis.
    Pascale RM; Simile MM; De Miglio MR; Muroni MR; Calvisi DF; Asara G; Casabona D; Frau M; Seddaiu MA; Feo F
    Hepatology; 2002 Jun; 35(6):1341-50. PubMed ID: 12029619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential Chemopreventive Role of Boldine Against Hepatocellular Carcinoma via Modulation of Cell Cycle Proteins in Rat Model.
    Subramaniam N; Kannan P; Sundaram J; Mari A; Velli SK; Salam S; Krishnan P; Balaraman G; Thiruvengadam D
    Anticancer Agents Med Chem; 2021; 21(18):2546-2552. PubMed ID: 33535961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effect of naringenin (citrus flavonone) on N-nitrosodiethylamine induced hepatocarcinogenesis in rats.
    Arul D; Subramanian P
    Biochem Biophys Res Commun; 2013 May; 434(2):203-9. PubMed ID: 23523793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. All-trans retinoic acid inhibits mesangial cell proliferation by up-regulating p21Waf1/Cip1 and p27Kip1 and down-regulating Skp2.
    Su B; Chen X; Zhong C; Guo N; He J; Fan Y
    J Nephrol; 2012; 25(6):1031-40. PubMed ID: 22344541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary supplementation of silymarin is associated with decreased cell proliferation, increased apoptosis, and activation of detoxification system in hepatocellular carcinoma.
    Gopalakrishnan R; Sundaram J; Sattu K; Pandi A; Thiruvengadam D
    Mol Cell Biochem; 2013 May; 377(1-2):163-76. PubMed ID: 23397134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical analyses at the late stage of tumor promotion by oxfendazole in a rat hepatocarcinogenesis model.
    Dewa Y; Nishimura J; Jin M; Kawai M; Saegusa Y; Kenmochi S; Shimamoto K; Harada T; Shibutani M; Mitsumori K
    Arch Toxicol; 2011 Feb; 85(2):155-62. PubMed ID: 20502879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.
    Wang J; Zhao J; Chu ES; Mok MT; Go MY; Man K; Heuchel R; Lan HY; Chang Z; Sung JJ; Yu J
    J Pathol; 2013 Aug; 230(4):441-52. PubMed ID: 23625826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of diosmin on apoptotic signaling molecules in N-nitrosodiethylamine-induced hepatocellular carcinoma in experimental rats.
    Perumal S; Langeshwaran K; Selvaraj J; Ponnulakshmi R; Shyamaladevi B; Balasubramanian MP
    Mol Cell Biochem; 2018 Dec; 449(1-2):27-37. PubMed ID: 29479636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melatonin modulates the oxidant-antioxidant imbalance during N-nitrosodiethylamine induced hepatocarcinogenesis in rats.
    Dakshayani KB; Subramanian P; Manivasagam T; Essa MM; Manoharan S
    J Pharm Pharm Sci; 2005 Aug; 8(2):316-21. PubMed ID: 16124941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-proliferative effects of qianliening capsules on prostatic hyperplasia in vitro and in vivo.
    Zhong X; Lin J; Zhou J; Xu W; Hong Z
    Mol Med Rep; 2015 Aug; 12(2):1699-708. PubMed ID: 25825141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemopreventive role of arabinoxylan rice bran, MGN-3/Biobran, on liver carcinogenesis in rats.
    Badr El-Din NK; Ali DA; Othman R; French SW; Ghoneum M
    Biomed Pharmacother; 2020 Jun; 126():110064. PubMed ID: 32278271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymoquinone, a bioactive component of black caraway seeds, causes G1 phase cell cycle arrest and apoptosis in triple-negative breast cancer cells with mutant p53.
    Sutton KM; Greenshields AL; Hoskin DW
    Nutr Cancer; 2014; 66(3):408-18. PubMed ID: 24579801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inductive effect of phytoglycoprotein (38 kDa) on G₀/G₁ arrest and apoptosis in diethylnitrosamine-treated ICR mice.
    Lee J; Lim KT
    Mol Cell Biochem; 2013 Mar; 375(1-2):31-8. PubMed ID: 23212447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of yellow tea extract on N-nitrosodiethylamine-induced liver carcinogenesis.
    Kujawska M; Ewertowska M; Adamska T; Ignatowicz E; Gramza-Michałowska A; Jodynis-Liebert J
    Pharm Biol; 2016 Sep; 54(9):1891-900. PubMed ID: 26839940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.